BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tampaki A, Gavriilaki E, Varelas C, Anagnostopoulos A, Vlachaki E. Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing. Blood Rev 2021;48:100805. [PMID: 33504459 DOI: 10.1016/j.blre.2021.100805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen-Goodspeed A, Idowu M. COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series. Am J Case Rep 2021;22:e931758. [PMID: 33941758 DOI: 10.12659/AJCR.931758] [Reference Citation Analysis]
2 Varelas C, Gavriilaki E, Sakellari I, Klonizakis P, Koravou E, Christodoulou I, Mavrikou I, Kourelis A, Chatzopoulou F, Chatzidimitriou D, Touloumenidou T, Papalexandri A, Anagnostopoulos A, Vlachaki E. Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center. JCM 2022;11:937. [DOI: 10.3390/jcm11040937] [Reference Citation Analysis]
3 Sabnis RW. Novel Bis-phosphoglycerate Mutase Modulators for Treating Sickle Cell Disease. ACS Med Chem Lett 2022;13:877-8. [DOI: 10.1021/acsmedchemlett.2c00181] [Reference Citation Analysis]
4 Sabnis RW. Novel Substituted Piperidine-2,6-dione Derivatives for Treating Sickle Cell Disease and β-Thalassemia. ACS Med Chem Lett 2021;12:1214-5. [PMID: 34413948 DOI: 10.1021/acsmedchemlett.1c00392] [Reference Citation Analysis]
5 Escamilla-Rivera V, Santhanakrishnan M, Liu J, Gibb DR, Forsmo JE, Foxman EF, Eisenbarth SC, Luckey CJ, Zimring JC, Hudson KE, Stowell SR, Hendrickson JE. Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice. Front Immunol 2021;12:704072. [PMID: 34249009 DOI: 10.3389/fimmu.2021.704072] [Reference Citation Analysis]